- Home
- Publications
- Publication Search
- Publication Details
Title
Zoledronic acid for adjuvant use in patients with breast cancer
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 11, Issue 3, Pages 333-349
Publisher
Informa UK Limited
Online
2011-03-21
DOI
10.1586/era.11.13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Task Force Report: Bone Health in Cancer Care
- (2017) Julie R. Gralow et al. Journal of the National Comprehensive Cancer Network
- Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
- (2016) Oliver Bock Clinical Interventions in Aging
- Abstract S4-5: Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer. The AZURE Trial (BIG 01/04)
- (2011) RE Coleman et al. CANCER RESEARCH
- Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
- (2010) H L Neville-Webbe et al. BRITISH JOURNAL OF CANCER
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Comparison of Denosumab Versus Zoledronic Acid for the Prevention of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases.
- (2010) A. Stopeck et al. CANCER RESEARCH
- The Plasticity of γδ T Cells: Innate Immunity, Antigen Presentation and New Immunotherapy
- (2010) Rita Casetti et al. Cellular & Molecular Immunology
- Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
- (2010) Jonathan R. Green et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Absolute Benefits of Aromatase Inhibitors in Adjuvant Treatment of Breast Cancer: Should We Know More?
- (2010) Bostjan Seruga et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
- (2010) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adding Zoledronic Acid to Endocrine Therapy in the Adjuvant Treatment of Hormone-Sensitive Breast Cancer in Premenopausal Women: A New Care Standard or a Provocative Idea?
- (2010) Kevin R. Fox Current Oncology Reports
- The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts
- (2009) Angela C. Hirbe et al. BONE
- The Dark Side of the Moon – the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management
- (2009) Richard Greil Breast Care
- Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy
- (2009) Filippo Montemurro et al. ENDOCRINE-RELATED CANCER
- Zoledronic acid: an unending tale for an antiresorptive agent
- (2009) Michele Caraglia et al. EXPERT OPINION ON PHARMACOTHERAPY
- Bilateral Low-Energy Simultaneous or Sequential Femoral Fractures in Patients on Long-Term Alendronate Therapy
- (2009) Craig M. Capeci et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
- Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
- (2009) Philippe L. Bedard et al. Nature Reviews Clinical Oncology
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Alendronate and Risk of Incident Atrial Fibrillation in Women
- (2008) Susan R. Heckbert et al. ARCHIVES OF INTERNAL MEDICINE
- Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole
- (2008) Nigel J. Bundred et al. CANCER
- Taxanes as primary chemotherapy for early breast cancer
- (2008) Federica Cuppone et al. CANCER
- Exploring the anti-tumour activity of bisphosphonates in early breast cancer
- (2008) M.C. Winter et al. CANCER TREATMENT REVIEWS
- Antitumor effects of bisphosphonates: Promising preclinical evidence
- (2008) Theresa A. Guise CANCER TREATMENT REVIEWS
- Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo
- (2008) P. D. Ottewell et al. CLINICAL CANCER RESEARCH
- Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
- (2008) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Zoledronsäure bei persistierenden isolierten Tumorzellen im Knochenmark bei Mammakarzinom
- (2008) B Rack et al. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- Aminobisphosphonate-activated γδ T cells in immunotherapy of cancer: doubts no more
- (2008) Nadia Caccamo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer
- (2008) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer
- (2008) Tomasz Burzykowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
- Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate
- (2008) Brett A. Lenart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole
- (2008) A. Brufsky et al. ONCOLOGIST
- Cancer Treatment-Induced Bone Loss: Pathophysiology and Clinical Perspectives
- (2008) A. M. Brufsky ONCOLOGIST
- Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers
- (2007) Ying-Ying Li et al. LUNG CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started